Clinical trial
Combination Paclitaxel, Carboplatin and Temozolomide
NCT00249964 · New Mexico Cancer Research Alliance, Other · Completed
Key facts
| NCT number | NCT00249964 |
|---|---|
| Title | Combination Paclitaxel, Carboplatin and Temozolomide |
| Official title | Phase I Dose Finding Clinical Trial of Combination Paclitaxel, Carboplatin and Temozolomide for Subjects With Solid Tumor Malignancies. |
| Lead sponsor | New Mexico Cancer Research Alliance, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Diseases, Cancer |
| Intervention type | Drug |
| Interventions | Combination Treatment - Cohort 1, Combination Treatment - Cohort 2, Combination Treatment - Cohort 3, Combination Treatment - Cohort 4 |
| Enrollment | 15 |
| Start date | Nov 1, 2003 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Nov 7, 2005 |
| Last update posted | Jan 20, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: